Financials
- Market Capitalization 74.64 M
- Employee 33
- Founded 2011
- CEO N/A
- Website www.elicio.com
- Headquarter Delaware, United States
- FIGI BBG00444GM02
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.84
Rapporto prezzo/fatturato
5 105.86
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4089 | RNXT RenovoRx, Inc. - Common Stock | 1.67 USD | +12.84% | +25.56% | +72.16% | +73.96% | 75.37 M USD | ||
| 4093 | NRXS Neuraxis, Inc. Common Stock | 5.97 USD | -1.32% | -3.24% | -7.15% | +9.94% | 74.97 M USD | ||
| 4105 | ANVS Annovis Bio, Inc. Common Stock | 1.72 USD | -4.97% | -6.01% | -2.82% | -25.54% | 73.28 M USD | ||
| 4108 | CRDF Cardiff Oncology, Inc. - Common Stock | 0.94 USD | -5.05% | +1.08% | +8.05% | -54.81% | 73.13 M USD |